BPOC, a pure-play healthcare investor, completed the acquisition of Rochester Clinical Research, a research site. Financial terms were not disclosed. “RCR’s successful history, scale and therapeutic expertise makes it the ideal platform from which to launch our broader strategy in the clinical research site market. We are thrilled to partner with Mark Scullion, the Larrabee family, and the entire team at RCR, to leverage our operational expertise and network to build a leading clinical research site business," Troy Phillips, BPOC Partner.